Federal Trade Commission v. Precision Patient Outcomes, Inc. and Margrett Priest Lewis - .more Government abuse

 Here is a link to the New Civil Liberties Alliance's case summary and more.

Another example of why the Government cannot be trusted to do the right thing - or act legally.

The ACLU has been politicized for many years. The New Civil Liberties Alliance is a far better alternative - help support it.

Here is the Case Summary.

-------------------------------

The Federal Trade Commission (FTC), in its initial filing before the U.S. District Court for the Northern District of California, has falsely accused Precision Patient Outcomes, Inc. (PPO) and CEO Margrett Lewis of unlawfully marketing and selling a dietary supplement called COVID Resist. The problem for FTC is PPO and Ms. Lewis never sold such a product—and FTC knows that. During six months or more of investigation, PPO provided FTC clear proof such sales never happened. So, there is simply no excuse for the agency to repeat this untrue claim, which undermines its entire groundless case. NCLA will vigorously defend our clients PPO and Ms. Lewis and expose FTC’s deceit here in the process.

Inspired by her personal experiences with health and wellness, Ms. Lewis became a tireless consumer and patient advocate. Drawing on a wide-cross section of information, she founded PPO, which develops precision medical solutions for wound care, scar management, and skin-renewing technologies. More recently, PPO began to develop and sell vitamin, mineral, and nutraceutical supplements. Prior to selling any supplements, PPO contacted FTC and asked it if there was any problem with the proposed product’s name and marketing. FTC would not say either way, so out of an abundance of caution and at great expense, PPO abandoned its trademarked name, removed and relabeled products, and changed its website and marketing. PPO never sold any “COVID Resist.”

Despite PPO’s drastic changes, the fact that it sold no product under the COVID Resist label, and that PPO ceased selling any product called “VIRUS Resist” before FTC filed suit, FTC has continued to pursue an enforcement action against the company—and against Ms. Lewis individually—under the newly enacted Covid-19 Consumer Protection Act. FTC seeks to monitor Ms. Lewis’s and PPO’s activities for the next 20 years and obtain substantial penalties for selling fewer than 250 bottles of a supplement containing ingredients thousands of physicians across the country recommend to support immune health. FTC lacks the statutory and constitutional authority to pursue these penalties or this action.

FTC unlawfully seized assets through disgorgement for 40 years until stopped by the Supreme Court in AMG Capital Management, LLC v. FTC in 2021. Now, the Commission is trying to eliminate truthful statements citizens make about their products and implement ruinous fines on a small business owner who did no wrong—and one who, in fact, sought advance agency approval.